22-Oxa-1α,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer

Carcinogenesis

Volumn 26, Issue 6, 2005, Pages 1044-1054

  Nakagawa, Kimie ^a   Sasaki, Yuko ^a   Kato, Shigeaki ^b   Kubodera, Noboru ^c   Okano, Toshio ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM; DRUG DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HYPERVITAMINOSIS; HYPOCALCEMIA; IN VITRO STUDY; LEWIS CARCINOMA; LUNG CANCER; METASTASIS; MOUSE; MUTANT; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECT; FEMALE; GENETICS; LUNG TUMOR; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CALCITRIOL; CALCIUM; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PARATHYROID HORMONE-RELATED PROTEIN; RECEPTORS, CALCITRIOL; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 22344433065     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi049     Document Type: Article

References (48)

1. Ginsberg, R.J., Vokes, E.E. and Raben, A. (1997) Cancer of the lung. In Devita, V.T. and Helman, S. Jr (eds) Cancer: Principles and Practice of Oncology, 5th edn. Lippincott-Raven, New York, Vol. 1, pp. 849-949.
2. 3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol. Immunother., 41, 37-45.
3. 3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization. Clin. Exp. Metastasis, 15, 102-110.
4. 3. Cancer Res., 47, 21-25.
5. Lokeshwar, B.L., Schwartz, G.G., Selzer, M.G., Burnstein, K.L., Zhuang, S.H., Block, N.L. and Binderup, L. (1999) Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol. Biomarkers Prev., 8, 241-248.
6. Cross, H.S., Kallay, E., Farhan, H., Weiland, T. and Manhardt, T. (2003) Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results Cancer Res., 164, 413-425.
7. 3 inhibits angiogenesis in vitro and in vivo. Circ. Res., 87, 214-220.
8. 3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett., 226, 58-62.
9. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology, 129, 832-837.
10. 3, in rats. J. Biochem., 115, 373-380.
11. 3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7, 12-dimethylbenz(a)anthracene. Anti Cancer Drugs, 2, 475-480.
12. Rashidi, B., Yang, M., Jiang, P., Baranov, E., An, Z., Wang, X., Moossa, A.R. and Hoffman, R.M. (2000) A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin. Exp. Res., 18, 57-60.
13. 3 is a preventive factor in the metastasis of lung cancer. Carcinogenesis, 26, 429-440.
14. Hovey, R.C., Goldhar, A.S., Baffi, J. and Vonderhaar, B.K. (2001) Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cell during mouse mammary gland development. Mol. Endocrinol., 15, 819-831.
15. 3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ., 11, 221-229.
16. Sakamoto, N., Tanaka, N.G., Tohgo, A. and Ogawa, H. (1986) Heparin plus cortisone acetate inhibit tumor growth by blocking endothelial cell proliferation. Cancer J., 1, 55-58.
17. Kragh, M., Hjarnaa, P-N.V., Bramm, E., Kristjansen, P.E.G., Rygaard, J. and Binderup, L. (2003) In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity. Int. J. Oncol., 22, 305-311.
18. Yoshizawa, T., Handa, Y., Uematsu, Y., Takeda, S., Sekine, K., Yoshihara, Y., Kawakami, T., Arioka, K., Sato, H., Uchiyama, Y., Masushige, S., Fukamizu, A., Matsumoto, T. and Kato, S. (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet., 16, 391-396.
19. Ferrara, N. (2001) Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol., 280, C1358-1366.
20. Burtis, W.J., Brady, T.G., Orloff, J.J., Ersbak, J.B., Warrell, R.P., Olson, B.R., Wu, T.L., Mitnick, M.E., Broadus, A.E. and Stewart, A.F. (1990) Immunochemical characterization of circulating parathyroid hormone-related protein in patients with hormonal hypercalcemia of cancer. N. Engl. J. Med., 322, 1106-1112.
21. Bendre, M., Gaddy, D., Nicholas, R.W. and Suva, L.J. (2003) Breast cancer metastasis to bone: it is not all about PTHrP. Clin. Orthop., 415(Suppl), S39-S45.
22. Maeda, Y., Yamato, H., Hirai, T., Kobori, N., Fujii, T., Kobayashi, Y., Saitoh, K., Inoguchi, E., Hakozaki, M. and Iijima, H. (1988) Antitumor and other effects of 24R, 25-dihydroxycholecalciferol in Lewis lung carcinoma causing abnormal calcium metabolism in tumor-bearing mice. Oncology, 45, 202-205.
23. Coven, V. and Kburi, F.R. (2003) Progress in lung cancer chemoprevention. Cancer Control, 10, 315-324.
24. 3 and its analogues on induction of apoptosis in breast cancer cells. J. Steroid Biochem. Mol. Biol., 58, 395-401.
25. James, S.Y., Mercer, E., Brady, L. and Colston, K. (1998) EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br. J. Pharmacol., 125, 953-962.
26. 3 and its 20-epimer. Biochem. Pharmacol., 60, 1937-1947.
27. 3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis. Steroids, 66, 327-337.
28. Mehtal, R.G. and Mehta, R.R. (2002) Vitamin D and cancer. J. Nutr. Biochem., 13, 252-264.
29. Abe-Hashimoto, J., Kikuchi, T., Matsumoto, T., Nishii, Y., Ogata, E. and Ikeda, K. (1993) Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res., 53, 2534-2537.
30. Barroga, E.F., Kadosawa, T., Okumura, M. and Fujinaga, T. (2000) Inhibitory effects of 22-oxa-calcitriol and all-trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo. Res. Vet. Sci., 68, 79-87.
31. 3 and its analogs on growth control and tumorigenesis. Front. Biosci., 6, 820-848.
32. 3 in HL-60 cells. Cancer Res., 56, 264-267.
33. Munker, R., Kobayashi, T., Elstner, E., Norman, A.W., Uskokovic, M. and Zhang, W. (1996) A new series of vitamin D analogs in highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood, 88, 2201-2209.
34. 2: antitumor activity against leukemia, myeloma, and colon cancer cells. J. Natl Cancer Inst., 95, 896-905.
35. 3 (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol. Biomark. Prev., 6, 727-732.
36. 3 dissociates production of interstitial collagenase and 92-kDa gelatinase in human mononuclear phagocytes. J. Biol. Chem., 269, 6485-6490.
37. Bian, J. and Sun, Y. (1997) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol., 17, 6330-6338.
38. Sato, H., Kita, M. and Seiki, M. (1993) v-Src activates the expression of 92-kDa Type IV collagenase gene through the AP-1 site and the GT box homologous to retinobrastoma control elements. J. Biol. Chem., 268, 23460-23468.
39. 3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood, 97, 2427-2433.
40. 3 of colon carcinogenesis induced by azoxymethane in Wister rats. Int. J. Cancer, 81, 730-733.
41. 3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr. Res., 23, 213-229.
42. 3 promotes vascularization of the chondro-osseous junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9. J. Bone Miner. Res., 17, 1604-1612.
43. Falzon, M. and Zong, J. (1998) The noncalcemic vitamin D analogs EB1089 and 22-oxacalcitriol suppress serum-induced parathyroid hormone-related peptide gene expression in a lung cancer cell line. Endocrinology, 139, 1046-1053.
44. 3-mediated transcriptional repression. Mol. Endocrinol., 10, 672-681.
45. Tovar Sepulveda, V.A. and Falzon, M. (2003) Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE. Mol. Cell. Endocrinol., 204, 51-64.
46. Ionescu, A.M., Schwarz, E.M., Vinson, C., Puzas, J.E., Rosier, R., Reynolds, P.R. and O'Keefe, R.J. (2001) PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling. J. Biol. Chem., 276, 11639-11647.
47. 3 on mouse thymus: role of extracellular calcium. Biochem. Biophys. Acta, 1289, 275-283.
48. Cantorna, M.T., Humpal-Winter, J. and DeLuca, H.F. (1999) Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J. Nutr., 129, 1966-1971.